Your browser doesn't support javascript.
loading
NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.
Witkowski, Matthew T; Lee, Soobeom; Wang, Eric; Lee, Anna K; Talbot, Alexis; Ma, Chao; Tsopoulidis, Nikolaos; Brumbaugh, Justin; Zhao, Yaqi; Roberts, Kathryn G; Hogg, Simon J; Nomikou, Sofia; Ghebrechristos, Yohana E; Thandapani, Palaniraja; Mullighan, Charles G; Hochedlinger, Konrad; Chen, Weiqiang; Abdel-Wahab, Omar; Eyquem, Justin; Aifantis, Iannis.
Afiliação
  • Witkowski MT; Department of Pathology and Laura & Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA. matthew.witkowski@cuanschutz.edu.
  • Lee S; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, USA. matthew.witkowski@cuanschutz.edu.
  • Wang E; Department of Pathology and Laura & Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA.
  • Lee AK; Department of Biology, New York University (NYU), New York, NY, USA.
  • Talbot A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ma C; The Jackson Laboratory for Genomic Medicine, Farmington, USA.
  • Tsopoulidis N; Department of Pathology and Laura & Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA.
  • Brumbaugh J; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Zhao Y; Department of Mechanical and Aerospace Engineering, New York University, New York, NY, USA.
  • Roberts KG; Department of Biomedical Engineering, New York University, New York, NY, USA.
  • Hogg SJ; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
  • Nomikou S; Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Ghebrechristos YE; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Thandapani P; Department of Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA.
  • Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Hochedlinger K; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Chen W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Abdel-Wahab O; Department of Pathology and Laura & Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA.
  • Eyquem J; Department of Pathology and Laura & Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA.
  • Aifantis I; Department of Pathology and Laura & Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, NY, USA.
Nat Immunol ; 23(10): 1424-1432, 2022 10.
Article em En | MEDLINE | ID: mdl-36138187
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Linfoma de Burkitt / Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article